News & Updates
Filter by Specialty:
Show Multimedia Only
Statin use may reduce mortality in early breast cancer
19 Jun 2024
byStephen Padilla
The addition of statins to standard adjuvant breast cancer treatment, particularly in combination with chemotherapy, appears to improve patient survival, suggests a study presented at ESMO Breast Cancer 2024.
Statin use may reduce mortality in early breast cancer
19 Jun 2024
Physical activity substantially cuts cirrhosis risk in MASLD patients
19 Jun 2024
byAudrey Abella
A study presented at DDW 2024 showed that adequate physical activity reduces the risk of cirrhosis in individuals with metabolic dysfunction-associated steatotic liver disease (MASLD).
Physical activity substantially cuts cirrhosis risk in MASLD patients
19 Jun 2024
Subcutaneous amivantamab compares favourably with intravenous dosing in EGFR-mutant NSCLC
18 Jun 2024
byJairia Dela Cruz
In previously treated patients with EGFR-mutated advanced non-small-cell lung cancer (NSCLC), subcutaneous (SC) amivantamab combined with lazertinib shows noninferior pharmacokinetic and efficacy profiles compared with the approved intravenous (IV) formulation of amivantamab, according to the phase III PALOMA-3 trial.